Inflammation and metabolic cardiomyopathy

Area of Science:

• Cardiovascular Science
• Metabolic Disease Research
• Inflammation Biology

Background:

• Excessive feeding contributes to chronic metabolic diseases like obesity and type 2 diabetes.
• Metabolic disturbances trigger low-grade inflammation in organs such as the liver and adipose tissue.
• Nutrients directly activate inflammatory signaling pathways, promoting pro-inflammatory mediators.

Purpose of the Study:

• To review recent advances in understanding the role of inflammation in metabolic cardiomyopathy.
• To elucidate the mechanisms linking metabolic disturbances to cardiac dysfunction.
• To highlight the progression of metabolic cardiomyopathy from subcellular inflammation to structural damage.

Main Methods:

• Literature review of recent scientific advances.
• Analysis of inflammatory signaling pathways in metabolic diseases.
• Examination of subcellular abnormalities in the heart due to metabolic disturbance.

Main Results:

• Metabolic cardiomyopathy is characterized by structural and functional alterations and fibrosis, independent of coronary artery disease or hypertension.
• Early stages involve subcellular inflammation (oxidative stress, mitochondrial dysfunction, ER stress, impaired calcium handling) leading to impaired myocardial relaxation.
• Advanced stages feature a cycle of subcellular abnormalities, inflammation, and neurohumoral activation causing cardiomyocyte injury, death, and fibrosis, impairing both diastolic and systolic functions.

Conclusions:

• Inflammation plays a critical role in the pathogenesis of metabolic cardiomyopathy.
• Metabolic disturbances initiate a cascade of events leading to progressive cardiac damage.
• Understanding these inflammatory mechanisms is key to addressing metabolic cardiomyopathy.